As a minimum, your "About this toolkit" section should contain the following information:
1.Purpose and audience
2. Key contact(s), including email address. This can be a generic rather than a personal contact.
3.If the toolkit is or includes a medical device, the regulatory information should be referenced in this section (UK CA mark, manufacturer details, Instructions for Use.)
You can also include a justification here for your toolkit or elements within it not being a medical device. The RDS team and InnoScot Health can help with this.
4. Privacy statement if the toolkit processes or stores person-identifiable data.
Your information governance department will help you in constructing a privacy statement if that is needed.
- Key author, reviewer and approver roles
- Details of clinical review of content at point of publication.
- Arrangements for review and updating of content - including responsibilities and planned review date(s).
- Outline of process used for systematic sourcing and evaluation of evidence to underpin the toolkit.
6. Corporate governance
- Details of the governance body and process which approved content and the toolkit at point of go-live.
- Details of the governance arrangements for ongoing development and updating of the toolkit.
- Confirmation that any guidance within the toolkit that references medicines has been signed off by the local Area Drug and Therapeutics Committee for territorial Boards or an equivalent governance group for national resources.
7. Confirmation that the toolkit meets the following additional quality assurance criteria:
- Risks to safety of patients/service users have been identified and mitigated.
- Functional testing, usability testing and user acceptance testing have been carried out.
- A plan has been defined for monitoring and acting on feedback and complaints.
a. Confirmation that the content within the toolkit complies with copyright legislation and that permission to embed content from external sources has been obtained where required.
b. If Flaticon images have been used, a statement that the RDS use of Flaticon images is covered by the licence paid by Tactuum as software provider of the RDS platform.
c. Copyright statement for your toolkit:
A copyright statement asserts the rights of the owner of the work and can also provide pre-emptive permission for copying or re-use of the work by others.
Copyright © NHS Greater Glasgow and Clyde 2023 (This excludes the works of 3rd parties as listed below. This information needs only to be included if there are other works included within your content)
Note: this is a basic statement of copyright, and assumes no other copyright subsists in the work. Also note that the owner of the work is separate from the author of the work. All work-based products will fall under the ownership of the employer.
Example 2: Creative Commons licences
Creative Commons licences give copyright owners a standardised way to grant others permission to re-use and adapt their creative work under copyright law. There are six Creative Commons licences, giving different levels of permission for re-use and adaptation.
This work is licensed under a Creative Commons Attribution 4.0 International License. (This excludes the works of 3rd parties as listed below. This information only needs only to be included if there are other works included within your content)
Note: you can choose your Creative Commons licence here Share your work - Creative Commons . The Creative Commons site also provides HTML code for the licence that can be embedded within the site. You can use these in conjunction with Example 1, so asserting your rights, but also providing permission under licence.
9. Accessibility statement
This should confirm that the content within your toolkit has been checked for accessibility. Any content that does not meet accessibility standards should be highlighted here. Note that accessibility of the RDS platform technology is confirmed in the RDS accessibility statement in "About this site."
See "Making content accessible" standard operating procedure for more information.